These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11950621)

  • 21. Reactive oxygen species in cardiovascular disease.
    Sugamura K; Keaney JF
    Free Radic Biol Med; 2011 Sep; 51(5):978-92. PubMed ID: 21627987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hypertension in renal disease.
    Baldwin DS; Neugarten J
    Am J Kidney Dis; 1985 Apr; 5(4):A57-70. PubMed ID: 3887904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidants in hypertension and cardiovascular disease.
    Schiffrin EL
    Mol Interv; 2010 Dec; 10(6):354-62. PubMed ID: 21263161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
    Swaminathan S; Shah SV
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):143-8. PubMed ID: 18277146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress in patients with cardiovascular disease and chronic renal failure.
    Popolo A; Autore G; Pinto A; Marzocco S
    Free Radic Res; 2013 May; 47(5):346-56. PubMed ID: 23438723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oxidative stress in nephrology].
    Pedzik A; Paradowski M; Rysz J
    Pol Merkur Lekarski; 2010 Jan; 28(163):56-60. PubMed ID: 20369727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidants for hypertension.
    Kitiyakara C; Wilcox CS
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):531-8. PubMed ID: 9818200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting reactive oxygen species in hypertension.
    Delles C; Miller WH; Dominiczak AF
    Antioxid Redox Signal; 2008 Jun; 10(6):1061-77. PubMed ID: 18321202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress and cardiovascular injury: Part II: animal and human studies.
    Griendling KK; FitzGerald GA
    Circulation; 2003 Oct; 108(17):2034-40. PubMed ID: 14581381
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting reactive oxygen species in hypertension.
    Cifuentes ME; Pagano PJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):179-86. PubMed ID: 16481886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PPAR agonists: elixir of eternal youth for the kidney?].
    Grosjean F
    G Ital Nefrol; 2010; 27(1):4. PubMed ID: 20191450
    [No Abstract]   [Full Text] [Related]  

  • 34. Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice.
    Sato-Horiguchi C; Ogawa D; Wada J; Tachibana H; Kodera R; Eguchi J; Nakatsuka A; Terami N; Shikata K; Makino H
    Nephron Exp Nephrol; 2012; 121(3-4):e97-e108. PubMed ID: 23307263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on Endothelial Functions of Proangiogenic Prokineticin.
    Nebigil CG
    Hypertension; 2016 Nov; 68(5):1091-1097. PubMed ID: 27672031
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitochondrion and its role in diabetic nephropathy.
    Khoshjou F; Dadras F
    Iran J Kidney Dis; 2014 Sep; 8(5):355-8. PubMed ID: 25194400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
    Lee WJ; Liu SH; Chiang CK; Lin SY; Liang KW; Chen CH; Tien HR; Chen PH; Wu JP; Tsai YC; Lai DW; Chang YC; Sheu WH; Sheu ML
    Antioxid Redox Signal; 2016 Feb; 24(4):217-231. PubMed ID: 26415004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compelling drug indications in diabetic and nondiabetic nephropathy.
    Ritz E; Dikow R; Zeier M
    Curr Hypertens Rep; 2004 Aug; 6(4):293-9. PubMed ID: 15257864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
    Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
    Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal oxygen exposure in rats leads to cardiovascular and renal alterations in adulthood.
    Yzydorczyk C; Comte B; Cambonie G; Lavoie JC; Germain N; Ting Shun Y; Wolff J; Deschepper C; Touyz RM; Lelièvre-Pegorier M; Nuyt AM
    Hypertension; 2008 Nov; 52(5):889-95. PubMed ID: 18852387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.